Semarion

About Semarion

Semarion develops SemaCyte microcarrier technology to accelerate adherent cell assays for drug discovery. Their ultra-miniaturized, mobile cell carriers can move cells with liquid handling tools, be magnetically steered, and frozen for assay-ready use, enabling flexible and scalable microplate workflows. The platform integrates with high-content imaging and high-throughput screening to boost throughput and efficiency in cell-based assays. The company is based in Cambridge, United Kingdom, and focuses on improving data quality and speed in in vitro cellular assays.